Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

EP Navarese, F Andreotti, V Schulze, M Kołodziejczak… - bmj, 2015 - bmj.com
Objective To assess the benefits and risks of short term (< 12 months) or extended (> 12
months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following …
被引用次数：376 相关文章
[PDF] core.ac.uk

[PDF][PDF] Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

EP Navarese, F Andreotti, V Schulze, M Kołodziejczak… - bmj, 2015 - core.ac.uk
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug
eluting stents: meta-analysis o Page 1 RESEARCH 1 OPEN ACCESS the bmj | BMJ …
[PDF] academia.edu

[PDF][PDF] Optimal duration of dual antiplatelet therapy ater percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

EP Navarese, F Andreotti, V Schulze, M Kołodziejczak… - bmj, 2015 - academia.edu
Optimal duration of dual antiplatelet therapy ater percutaneous coronary intervention with drug
eluting stents: meta-analysis of Page 1 RESEARCH 1 OPEN ACCESS the bmj | BMJ …

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

EP Navarese, F Andreotti, V Schulze… - BMJ: British Medical …, 2015 - search.proquest.com
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug
eluting stents: meta-analysis o Page 1 RESEARCH 1 OPEN ACCESS the bmj | BMJ …

[引用][C] Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: Meta-analysis of randomised controlled trials

EP Navarese, V Schulze, M Kolodziejczak… - BMJ: British Medical …, 2015 - elibrary.ru

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

EP Navarese, F Andreotti, V Schulze… - BMJ (Clinical …, 2015 - pubmed.ncbi.nlm.nih.gov
Objective To assess the benefits and risks of short term (< 12 months) or extended (> 12
months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following …

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials.

EP Navarese, F Andreotti, V Schulze… - … (Clinical Research ed …, 2015 - europepmc.org
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with
drug eluting stents: meta-analysis of randomised controlled trials. - Abstract - Europe PMC …
[PDF] eur.nl

[PDF][PDF] Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

EP Navarese, F Andreotti, V Schulze, M Kołodziejczak… - bmj, 2015 - pure.eur.nl
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug
eluting stents: meta-analysis o Page 1 RESEARCH 1 OPEN ACCESS the bmj | BMJ …

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: Meta-analysis of randomised controlled trials

EP Navarese, F Andreotti, V Schulze, M Kołodziejczak… - BMJ (Online), 2015 - repub.eur.nl
OBJECTIVE: To assess the benefits and risks of short term (12 months) dual antiplatelet
therapy (DAPT) versus standard 12 month therapy, following percutaneous coronary …
[PDF] unicatt.it

[PDF][PDF] Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

EP Navarese, F Andreotti, V Schulze, M Kołodziejczak… - BMJ, 2015 - publicatt.unicatt.it
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug
eluting stents: meta-analysis o Page 1 RESEARCH 1 OPEN ACCESS the bmj | BMJ …